Glaxo Smith Kline 00173088710 - Trelegy… | USA MedPremium
Trelegy Ellipta Inhaler: Fluticasone/Umeclidinium/Vilanterol 100/62.5/25 mcg
USAMP#92238794SKU: 00173088710Trelegy™ Ellipta
License Required
Product Spotlight
Comprehensive treatment for COPD and asthma with Trelegy Ellipta Inhaler, combining Fluticasone, Umeclidinium, and Vilanterol.
Each metered-dose inhaler contains 30 doses of a triple-action formula designed to improve breathing and manage symptoms.
Manufactured by GlaxoSmithKline, this inhaler is a convenient, once-daily, latex-free solution for patients.
Features a dosage strength of 100 mcg Fluticasone Furoate, 62.5 mcg Umeclidinium Bromide, and 25 mcg Vilanterol Trifenatate to ensure effective symptom control.
Designed for easy use with a powder formulation that provides a precise dose with each inhalation.
